类有机物
免疫系统
诱导多能干细胞
移植
细胞生物学
癌症研究
效应器
干细胞
生物
小岛
免疫学
细胞毒性
转录组
医学
主要组织相容性复合体
重编程
细胞
免疫耐受
免疫疗法
MHC I级
抗原
作者
Anna Ada Dattoli,Matthew E. Brown,Bradley Pearson,Zachary Feinstein,Ying Lan,Vasumati Polavarapu,Max Zhou,Ryan Nachman,Yosip Kelemen,Shahin Rafii,Rémi J. Creusot,Todd M. Brusko,Qiao Zhou,Xiaofeng Huang
出处
期刊:
[Cold Spring Harbor Laboratory]
日期:2026-07-13
标识
DOI:10.64898/2026.07.08.736836
摘要
Summary Gastric insulin-secreting organoids (GINS) represent a promising source of β-like cells for type 1 diabetes (T1D) therapy. In same-donor comparisons with induced pluripotent stem cell-derived islets (iPSC-islets), GINS displayed robust glucose responsiveness and reduced expression of key T1D autoantigens. Importantly, GINS exhibited decreased susceptibility to cytotoxicity mediated by engineered HLA-matched preproinsulin-specific effector T cells (Avatar Teffs) and a distinct transcriptional profile enriched for immune-modulatory and stress-adaptive gene programs. To enhance immune evasion, we engineered gastric stem cells to overexpress Programmed Death Ligand 1 (PD-L1) in an inducible manner. PD-L1 + GINS maintained normal functionality, while exhibiting improved survival under allogeneic Avatar Teff challenge in a MHC class I-independent fashion. We evaluated PD-L1-mediated protection against autologous Avatar Teff attack using an endothelialized microfluidic platform recapitulating physiologic immune interactions. T cells show reduced infiltration into PD-L1⁺ GINS, resulting in significantly higher organoid viability compared to control GINS. Together, these findings identify GINS as a functional and engineerable β-like cell platform with intrinsic hypoimmunogenic features, and support PD-L1 engineering as a strategy to enhance immune protection for both allogeneic and autologous transplantation in T1D.
科研通智能强力驱动
Strongly Powered by AbleSci AI